tiprankstipranks
EXACT Therapeutics AS (DE:56F)
FRANKFURT:56F
Germany Market
56F
EXACT Therapeutics AS
RESEARCH TOOLSreports

EXACT Therapeutics AS (56F) Financial Statements

0 Followers

EXACT Therapeutics AS Financial Overview

EXACT Therapeutics AS's market cap is currently €8.16M. The company's EPS TTM is €-0.053994470999999995; its P/E ratio is -0.24; EXACT Therapeutics AS is scheduled to report earnings on April 9, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18Dec 17
Income Statement
Total Revenue
Gross Profit-----
Operating Income$ -59.11M$ -34.70M$ -15.98M$ -7.62M$ -4.95M
EBITDA$ -56.66M$ -31.98M$ -14.41M$ -7.45M$ -4.76M
Net Income$ -58.59M$ -33.09M$ -14.82M$ -7.59M$ -4.91M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 117.63M$ 170.23M$ 52.10M$ 63.23M$ 20.02M
Total Debt$ 1.71M$ 37.89K$ 184.07K$ 0.00$ 0.00
Net Debt$ -101.52M$ -159.38M$ -44.85M$ -58.67M$ -15.15M
Total Liabilities$ 11.89M$ 10.58M$ 9.87M$ 6.17M$ 11.68M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -56.74M$ -29.95M$ -13.86M$ -12.25M-
Operating Cash Flow$ -55.11M$ -25.99M$ -12.46M$ -12.25M-
Investing Cash Flow
Financing Cash Flow

EXACT Therapeutics AS Earnings and Revenue History

Income Statement >

EXACT Therapeutics AS Debt to Assets

Balance Sheet >

EXACT Therapeutics AS Cash Flow

Cash Flow >

EXACT Therapeutics AS Forecast EPS vs Actual EPS

Earnings >